Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
02/2008
02/28/2008WO2008023720A1 Urea compound or salt thereof
02/28/2008WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators
02/28/2008WO2008022771A1 Amides as sphingomyeline inhibitors
02/28/2008WO2007090617A3 Thiadiazole derivatives for the treatment of neuro degenerative diseases
02/28/2008CA2665804A1 Urea compound or salt thereof
02/28/2008CA2659991A1 Amides as sphingomyeline inhibitors
02/27/2008CN101130526A Aryl carbonyl derivatives as therapeutic agents
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/21/2008WO2008020256A2 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use
02/21/2008WO2008020255A1 Benzo[1,2,3]thiadiazine derivatives
02/21/2008WO2007103456A3 Piperazine and piperidine biaryl derivatives
02/21/2008US20080045556 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy
02/21/2008US20080045546 Tetradydro-Naphthalene And Urea Derivatives
02/21/2008CA2661082A1 Benzo[1,2,3]thiadiazine derivatives
02/21/2008CA2660890A1 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use
02/20/2008EP1889619A1 Use of thiadiazolidine-derived compounds as neurogenic agents
02/20/2008CN101128445A 4-cyclopropyl-1,2,3-thiadiazole derivative, agrohorticultural plant disease controlling agent, and method for using the same
02/20/2008CN101128413A Substituted oxyarenes
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/20/2008CN100370363C Azine-based dimeric charge transport materials
02/19/2008CA2210072C Crop protection products
02/14/2008WO2008019090A2 Agonists of the sphingosine-1-phosphate receptor
02/14/2008WO2008017164A1 Thiophenecarboxamide derivatives as ep4 receptor ligands
02/14/2008US20080039464 Compounds Which Modulate The CB2 Receptor
02/14/2008US20080039442 Compounds With Kv4 Ion Channel Activity
02/14/2008CA2660133A1 Thiophenecarboxamide derivatives as ep4 receptor ligands
02/13/2008EP1638951B1 Cyclohexyl sulphones as gamma-secretase inhibitors
02/13/2008EP1450814A4 Methods of inhibiting metastases
02/13/2008EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
02/07/2008WO2008016692A2 Chemical compounds
02/07/2008WO2008016674A1 Agonists of the sphingosine- 1- phosphate receptor (slp)
02/07/2008US20080033012 Enzyme inhibitors
02/07/2008US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
02/07/2008US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one
02/07/2008CA2659473A1 Chemical compounds
02/05/2008US7326790 Diphenylisoxazole compounds and hydro isomers thereof
02/05/2008US7326695 Anti-bacterial agents based upon oxoanion binding
01/2008
01/31/2008US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
01/31/2008CA2657247A1 Compounds which modulate the cb2 receptor
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/29/2008CA2291688C Novel sulfur transfer reagents for oligonucleotide synthesis
01/24/2008WO2008009734A1 Macrocyclic lactams
01/24/2008US20080021027 Novel benzimidazole derivatives
01/24/2008CA2656869A1 Macrocyclic lactams
01/23/2008EP1879548A2 Process for coloring keratin fibers comprising metal complexes
01/23/2008EP1556354B1 Therapeutic piperazine derivates useful for treating pain
01/23/2008CN101108830A Cyclic compound, process for producing the same, and pest control agent
01/17/2008WO2008008394A1 Tizanidine succinate salt forms and methods of making and using the same
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk)
01/17/2008US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
01/17/2008CA2658097A1 Pentadienamide derivatives
01/16/2008EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity
01/15/2008US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
01/10/2008US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione
01/09/2008CN101103000A Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
01/09/2008CN101100461A Thiadiazoles derivative for halopolymer vulcanization crosslinking and synthetic method for the same
01/09/2008CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas
01/08/2008CA2254558C A process for producing 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate and trifluoroacetic acid
01/03/2008WO2008000438A1 Insecticidal compounds
01/03/2008WO2008000408A1 Cxcr2 antagonists
01/03/2008US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use
01/03/2008US20080003214 Medicaments Comprising Carbonyl Compounds, And The Use Thereof
01/02/2008CN101096366A Method for synthesizing disulfo-dithiazole ketone
01/02/2008CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/01/2008USRE39991 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/2007
12/27/2007US20070299116 Human protein tyrosine phosphatase inhibitors and methods of use
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299064 Pesticidal Heterocyclic Dihaloallyl Compounds
12/27/2007US20070299052 Inhibitors of IAP
12/26/2007EP1870404A1 Agent for treatment of hematopoietic tumor
12/26/2007CN101092405A Derivative of new benzothiadiazines, preparation method and usage
12/20/2007US20070293510 Thiadiazole compounds and use thereof
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/19/2007EP1867640A1 Agent for treatment of solid tumor
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1866298A2 Hydroxysteroid dehydrogenase inhibitors
12/19/2007EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN100355739C Diazosulfide derivative, and its synthesizing method and activity for inducing tobacco to resist tobacco mosaic virus
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/12/2007EP1864970A1 Process for producing disulfonyl fluoride compound
12/12/2007EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
12/12/2007CN101087770A Tricyclic spacer systems for nonlinear optical devices
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/06/2007WO2007140233A1 Inhibitors of polo-like kinases
12/06/2007CA2647592A1 Inhibitors of polo-like kinases
12/05/2007CN101083982A Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
12/04/2007US7304162 Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
12/04/2007CA2199145C Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
11/2007
11/29/2007WO2007136051A1 Optical recording material, optical recording medium using the optical recording material, and method for reproducing optical recording medium
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007US20070276017 Thiadiazoline Derivative
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/27/2007US7301032 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 100